Cheng Yan

845 total citations
38 papers, 543 citations indexed

About

Cheng Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cheng Yan has authored 38 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Cheng Yan's work include Ferroptosis and cancer prognosis (8 papers), Ubiquitin and proteasome pathways (4 papers) and RNA modifications and cancer (4 papers). Cheng Yan is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Ubiquitin and proteasome pathways (4 papers) and RNA modifications and cancer (4 papers). Cheng Yan collaborates with scholars based in China, United States and Australia. Cheng Yan's co-authors include Yong Wang, Songgang Li, Jianwei Wang, Shu-you Peng, Zhiping Zhang, Jiangtao Li, Jiyu Li, Zhiwei Quan, Xiangsong Wu and Yingbin Liu and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and The Journal of Physical Chemistry B.

In The Last Decade

Cheng Yan

33 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Yan China 13 346 145 118 112 75 38 543
Kelly Su Taiwan 6 287 0.8× 113 0.8× 184 1.6× 139 1.2× 81 1.1× 7 553
Zhenhai Lin China 9 329 1.0× 150 1.0× 143 1.2× 96 0.9× 70 0.9× 15 536
Yinlu Ding China 15 305 0.9× 96 0.7× 151 1.3× 91 0.8× 90 1.2× 33 559
Chuntian Huang China 11 380 1.1× 155 1.1× 165 1.4× 107 1.0× 118 1.6× 13 587
Angelo Gámez‐Pozo Spain 15 427 1.2× 257 1.8× 169 1.4× 151 1.3× 45 0.6× 51 718
Guang-Ang Tian China 13 324 0.9× 180 1.2× 166 1.4× 93 0.8× 64 0.9× 20 582
Yi‐Fang Yang Taiwan 12 357 1.0× 224 1.5× 102 0.9× 68 0.6× 38 0.5× 29 505
Andrew Trotta Australia 13 453 1.3× 154 1.1× 125 1.1× 122 1.1× 37 0.5× 17 693
Timothy Wai Ho Shuen Singapore 12 350 1.0× 201 1.4× 135 1.1× 83 0.7× 36 0.5× 22 563

Countries citing papers authored by Cheng Yan

Since Specialization
Citations

This map shows the geographic impact of Cheng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Yan more than expected).

Fields of papers citing papers by Cheng Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Yan. The network helps show where Cheng Yan may publish in the future.

Co-authorship network of co-authors of Cheng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Yan. A scholar is included among the top collaborators of Cheng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Yan. Cheng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Lei, et al.. (2025). Medium effects of polysaccharides: bidirectional regulation of invertase activity by sodium alginate and fenugreek gum. Food Chemistry. 498(Pt 1). 147108–147108. 1 indexed citations
3.
Yan, Cheng, et al.. (2025). Diagnostic accuracy of high-resolution melting curve analysis for discrimination of oncology-associated EGFR mutations: a systematic review and meta-analysis. Journal of International Medical Research. 53(2). 3649372061–3649372061.
4.
Li, Zhenzhen, et al.. (2025). Enhanced or Inhibited Activity of Lipase in Macromolecular Media: Quantification and Prediction. The Journal of Physical Chemistry B. 129(9). 2335–2347. 1 indexed citations
5.
Tian, Rui, et al.. (2025). Overexpression of KIF2C amplifies tamoxifen resistance and lung metastasis of breast cancer through PLK1/C-Myc pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(9). 12133–12146.
6.
Zhang, Shenqing, Huaijiang Xiang, Youqi Tao, et al.. (2024). Inhibitor Development for α-Synuclein Fibril’s Disordered Region to Alleviate Parkinson’s Disease Pathology. Journal of the American Chemical Society. 146(41). 28282–28295. 14 indexed citations
7.
Liu, Xiangjuan, et al.. (2024). TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer. Translational Cancer Research. 13(8). 4159–4171. 1 indexed citations
8.
Yan, Cheng, et al.. (2024). FDAA: A feature distribution-aware transferable adversarial attack method. Neural Networks. 178. 106467–106467.
9.
Li, Feng, et al.. (2022). Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Scientific Reports. 12(1). 19857–19857. 7 indexed citations
10.
Yan, Cheng, et al.. (2022). System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. Journal of Translational Medicine. 20(1). 452–452. 97 indexed citations
11.
Yan, Cheng, et al.. (2022). Comprehensive Analysis of the Immune and Prognostic Implication of TRIM8 in Breast Cancer. Frontiers in Genetics. 13. 835540–835540. 4 indexed citations
12.
Liu, Yun, Peng Su, Xin Li, et al.. (2021). ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. Cancer Science. 112(7). 2714–2727. 10 indexed citations
13.
Niu, Zhiguo, Xin Li, Qingsong Huang, et al.. (2020). The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression. Journal of Cancer. 11(23). 6992–7000. 29 indexed citations
14.
Wu, Lirong, Cheng Yan, Xuan Pan, et al.. (2019). Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma. BMC Cancer. 19(1). 843–843. 31 indexed citations
15.
Chen, Chao, Xiuli Chen, Menghong Xu, et al.. (2019). Graphically encoded suspension array for multiplex immunoassay and quantification of autoimmune biomarkers in patient sera. Biosensors and Bioelectronics. 132. 47–54. 12 indexed citations
16.
Jin, Chun, Cheng Yan, Yi Zhang, et al.. (2019). A mutational profile in multiple thymic squamous cell carcinoma. Gland Surgery. 8(6). 691–697. 2 indexed citations
17.
Su, Pan, Sheng Chen, Haiyan Zhou, et al.. (2016). Novel Function of Extracellular Matrix Protein 1 in Suppressing Th17 Cell Development in Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 197(4). 1054–1064. 22 indexed citations
18.
Liu, Yu, et al.. (2015). Production of Herbicide-Resistant Medicinal Plant Salvia miltiorrhiza Transformed with the Bar Gene. Applied Biochemistry and Biotechnology. 177(7). 1456–1465. 3 indexed citations
19.
20.
Yan, Cheng. (2004). Study of Dong Nationality Village and Its Culture. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026